Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore ways to earn money while you sleep through smart investments and strategies. Let your money work for you!
27,858 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Bitcoin hovers near a pivotal zone as bulls and bears clash. Analysts warn of a potential break below key supports, s...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
Bitcoin hovered near the $60,000 mark but briefly slid toward $58,000 as ETF outflows intensified and inflation data ...
Qualcomm rolls out a five year plan to compete with Nvidia in AI data center chips, aiming for multi billion dollar A...
A California adviser is deepening collaboration between financial advisers and reverse mortgage lenders to integrate ...
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
A personal financial disclosure reveals Trump earned more than a billion dollars from crypto ventures last year, incl...
Bitwise CIO Matt Hougan argues that Strategy's STRC selloff reflects end-of-cycle deleveraging preceding a bitcoin bo...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
XRP closed June with a 22% plunge, yet history suggests July could bring a pronounced rebound as ETF inflows persist ...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...